Skip to main content

BARCLAYS PLC

Position in ADCT — ADC Therapeutics SA

CIK 312069 LONDON, X0

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$173,755
-$395,937 QoQ
Shares Held
46,335
-71.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. ADCT ranks #34 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $173,755 46,335
2025-12-31 $569,692 161,386
2025-09-30 $521,840 130,460
2025-06-30 $389,690 145,407
2025-03-31 $142,457 101,034
2024-12-31 $281,575 141,495
2024-09-30 $402,377 127,739
2024-06-30 $106,962 33,849
2023-06-30 $677,088 314,925
2023-03-31 $651,830 334,272